BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:OPK-88006 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of OPK-88006\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07512427-6935@assetmemo.bio
DTSTAMP:20261121T005652Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:OPK-88006: Phase 1/2 readout est. (NCT07512427)
DESCRIPTION:OPK-88006\, phase 1/2\, MASH / NASH.\nStudy: Phase 1/2 Study of
  OPK-88006 in Healthy and Presumed MASH Participants\nEstimated primary co
 mpletion: December 2027. This is a ClinicalTrials.gov estimate\, not a con
 firmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/d
 rug/opk-88006#upcoming-events\nRegistry record: https://clinicaltrials.gov
 /study/NCT07512427
URL:https://assetmemo.bio/drug/opk-88006#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
